second line treatment - Globe Thesis

Keyword [second line treatment] Result: 41 - 60 \| Page: 3 of 4
41.	Efficacy Of Bevacizumab Combined With Chemotherapy As First-line And Second-line Treatment In Metastatic Colorectal Cancer
42.	Clinical Efficacy Of Apatinib In Second-line Treatment Failure Of Extensive Stage Small Cell Lung Cancer
43.	Clinical Analysis Of Anti-N-Methyl-D-Aspartate Receptor Encephalitis In Adults And Children
44.	A Retrospective Multicenter Study Of A Combination Of S-1 And Non-platinum-based Chemotherapy As Second-line Therapy For Advanced Non-small Cell Lung Cancer Patients
45.	Efficacyandsafetyofsecond-lineirinotecancombinedwith Anlotinibinthetreatmentofsmallcelllungcancer
46.	Clinical Observation Of Anlotinib Combined With Docetaxel In The Treatment Of Advanced Non-small Cell Lung Cancer
47.	Effects On Anlotinib Plus Chemotherapy As Second-line Therapy In Small Cell Lung Cancer
48.	Clinical Efficacy And Safety Of Apatinib Combined With Chemotherapy In The Second-line Treatment Of Small Cell Lung Cancer
49.	The Efficacy And Safety Of Irinotecan In Combination With Anlotinib In The Second-line Treatment Of Small Cell Lung Cancer
50.	Clinical Analysis Of Second-line Treatment Of Chronic Myeloid Leukemia With Nilotinib And Dasatinib
51.	Clinical Efficacy Observation Of First-line And Second-line Treatment With Nilotinib In Chronic Myeloid Leukemia
52.	Efficacy Of Bevacizumab Combined With Chemotherapy As First-line And Second-line Treatment In Advanced Non-squamous Non-small Cell Lung Cancer
53.	Real-world Retrospective Study Of Second-line Treatment With Ratitrexed Regimen In Advanced Colorectal Cancer
54.	Efficacy And Safety Of Immunotherapy Versus Chemotherapy As Second-line Treatment On Esophageal Squamous Cell Carcinoma:Meta Analysis
55.	Efficacy And Safety Of PD-1/PD-L1 Inhibitors Versus Chemotherapy In Second-line Treatment Of Advanced Esophageal Cancer:A Meta-Analysis Of Randomized Controlled Trials
56.	Efficacy And Safety Of Programmed Cell Death 1 Inhibitor Monotherapy Versus Chemotherapy As Second-Line Treatment For Advanced Esophageal Cancer:A Meta-Analysis
57.	Efficacy And Safety Analysis Of Immune Checkpoint Inhibitors Combined With Chemotherapy And Chemotherapy Alone In Second-line Treatment Of Patients With Advanced Biliary Malignancy
58.	A Prospective Clinical Study Evaluating The Efficacy And Safety Of Combination Therapy Of Anlotinib Hydrochloride And Irinotecan In The Second-line Treatment Of Patients With Advanced Esophageal Squamous Cell Carcinoma
59.	Clinical Efficacy And Safety Of Apatinib Mesylate In Second-line Treatment Of Advanced Cholangiocarcinoma
60.	Phase ? Study Of Anlotinib Plus Sintilimab As Second-line Treatment For Patients With Advanced Biliary Tract Cancers
<<First <Prev Next> Last>> Jump to